Serum biomarkers for inflammatory bowel disease
P Chen, G Zhou, J Lin, L Li, Z Zeng, M Chen… - Frontiers in …, 2020 - frontiersin.org
Background: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative
colitis, is a chronic, inflammatory disorder of the gastrointestinal tract. As the novel …
colitis, is a chronic, inflammatory disorder of the gastrointestinal tract. As the novel …
MicroRNA biomarkers in IBD—differential diagnosis and prediction of colitis-associated cancer
Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC).
These are chronic autoimmune diseases of unknown etiology affecting the gastrointestinal …
These are chronic autoimmune diseases of unknown etiology affecting the gastrointestinal …
Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR
F Marabita, P De Candia, A Torri… - Briefings in …, 2016 - academic.oup.com
The high-throughput analysis of microRNAs (miRNAs) circulating within the blood of healthy
and diseased individuals is an active area of biomarker research. Whereas quantitative real …
and diseased individuals is an active area of biomarker research. Whereas quantitative real …
Inflammatory bowel disease biomarkers
Inflammatory bowel disease (IBD) is characterized as chronic inflammation in the
gastrointestinal tract, which includes two main subtypes, Crohn's disease and ulcerative …
gastrointestinal tract, which includes two main subtypes, Crohn's disease and ulcerative …
[HTML][HTML] Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
Inflammatory bowel diseases (IBDs) are chronic disorders of modern society, requiring
management strategies aimed at prolonging an active life and establishing the exact …
management strategies aimed at prolonging an active life and establishing the exact …
The current status of molecular biomarkers for inflammatory bowel disease
Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …
Biomarkers of inflammation in inflammatory bowel disease: how long before abandoning single-marker approaches?
G Dragoni, T Innocenti, A Galli - Digestive Diseases, 2021 - karger.com
Background: Inflammatory bowel disease (IBD) is a chronically relapsing disease with a
continuous need for proactive monitoring to decide appropriate treatments and follow-up …
continuous need for proactive monitoring to decide appropriate treatments and follow-up …
MicroRNA and gut microbiota: Tiny but mighty—Novel insights into their cross-talk in inflammatory bowel disease pathogenesis and therapeutics
M Casado-Bedmar, E Viennois - Journal of Crohn's and Colitis, 2022 - academic.oup.com
Abstract MicroRNAs [miRNAs], small non-coding RNAs, have recently been described as
crucial contributors to intestinal homeostasis. They can interact with the gut microbiota in a …
crucial contributors to intestinal homeostasis. They can interact with the gut microbiota in a …
Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases
K Schönauen, N Le, U von Arnim… - Inflammatory bowel …, 2018 - academic.oup.com
Background Assessment of the disease activity in inflammatory bowel disease (IBD) is
essential for adequate treatment management and reliable noninvasive biomarkers for …
essential for adequate treatment management and reliable noninvasive biomarkers for …
Differentially expressed miRNAs in ulcerative colitis and Crohn's disease
R Yarani, A Shojaeian, O Palasca… - Frontiers in …, 2022 - frontiersin.org
Differential microRNA (miRNA or miR) regulation is linked to the development and progress
of many diseases, including inflammatory bowel disease (IBD). It is well-established that …
of many diseases, including inflammatory bowel disease (IBD). It is well-established that …